TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 5 | 4 | 5 | 22 | 13 | -4 | 7 |
| P | %wins | 100 | 100 | 100 | 100 | 50 | 50 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/06 17:13 | 9/15/06 | OXGN | Oxigene Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chin Richard | MA | DO | P,CEO | P | 186 | 4.09 | 0 | 45 | 76 | 105 | D | -30 | -21 | 2 | 17 | 16 | 22 | 3 | 4 | 4 | 3 | 0 | 22 | -6 | -17 |
8/3/06 10:38 | 8/1/06 | OXGN | Oxigene Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chin Richard | MA | DO | P,CEO | P | 66 | 3.30 | 0 | 20 | 50 | 60 | D | -35 | -29 | -21 | -24 | -11 | -6 | 14 | 6 | 5 | 4 | 9 | 21 | 32 | 10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |